Walgreens Boots Alliance, Inc. which can be found using ticker (WBA) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between 45 and 27 with the average target price sitting at $33.53. Now with the previous closing price of $29.35 this would indicate that there is a potential upside of 14.2%. There is a 50 day moving average of $30.34 while the 200 day moving average is $34.61. The company has a market cap of 25.09B. The stock price for the company is currently is currently 29.07 USD
The potential market cap would be $28,669,002,208 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 157.64 and a 0.67% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
